Alzheimer's Society's flagship Drug Discovery programme is a new approach to developing treatments for dementia. To explain how the programme works the Alzheimer's Society have created a short Drug Discovery video.
Drug Discovery Programme - Alzheimer's Society Dementia Research
Northwestern University and Washington University School of Medicine researchers have developed the first example of a bioelectronic medicine: an implantable, biodegradable wireless device that speeds nerve regeneration and improves healing of a damaged nerve. Their device delivered pulses of electricity to damaged nerves in rats after a surgical repair process, accelerating the regrowth of nerves and enhancing the recovery of muscle strength and control. The device is the size of a dime and the thickness of a sheet of paper and dissolves in the body after about two weeks.
CryostaX® hepatocytes are created using a patented process that produces unique single-donor cell pellets. This format allows for distinct benefits to hepatocyte performance, efficiency in the lab, and test system design, precipitating the potential discontinuation of cryopreserved hepatocytes prepared from traditional methods. This webinar will discuss the technology, its optimal utilization and benefitsWATCH NOW
2nd International Conference on Biological & Pharmaceutical Sciences
Jul 12 - Jul 13, 2019